Cochrane Abstracts
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prophylactic Versus Selective Use of Surfactant in Preventing Morbidity and Mortality in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433290/all/Prophylactic_versus_selective_use_of_surfactant_in_preventing_morbidity_and_mortality_in_preterm_infants.
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433290/all/Prophylactic_versus_selective_use_of_surfactant_in_preventing_morbidity_and_mortality_in_preterm_infants. Accessed January 19, 2025.
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433290/all/Prophylactic_versus_selective_use_of_surfactant_in_preventing_morbidity_and_mortality_in_preterm_infants
Prophylactic Versus Selective Use of Surfactant in Preventing Morbidity and Mortality in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433290/all/Prophylactic_versus_selective_use_of_surfactant_in_preventing_morbidity_and_mortality_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
ID - 433290
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433290/all/Prophylactic_versus_selective_use_of_surfactant_in_preventing_morbidity_and_mortality_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
